Cytogenetic study in peripheral blood of melanoma patients;Estudio citogenético en sangre periférica de pacientes con melanoma

Investigacion Clinica

Volumn 50, Issue 2, 2009, Pages 173-186

  Rondón Lagos, Sandra ^a   Rangel, Nelson ^a   Ramírez, Sandra ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Chromosomal anomalies; Cytogenetic; Melanoma

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CHROMOSOME 17; CHROMOSOME 9; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSING OVER; CYTOGENETICS; GENETIC PREDISPOSITION; HUMAN; MELANOMA; MONOSOMY; TRISOMY; X CHROMOSOME; ANEUPLOIDY; BLOOD; CHROMOSOME BANDING PATTERN; CHROMOSOME FRAGILE SITE; FEMALE; GENETICS; KARYOTYPING; MALE; MIDDLE AGED; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME FRAGILE SITES; FEMALE; HUMANS; KARYOTYPING; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; YOUNG ADULT;

EID: 70349562561     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Barzilai D, Singer M. The potential impact on melanoma mortality of reducing rates of suboptimal excision margins. 2003; 120(6):1067-1072.
2. GLOBOCAN. Cancer Incidence, Mortality and Prevalence Worldwide, in IARC Cancer Base, Lyon, IARC Press. 2002.
3. Pardo C, Murillo R, Piñeros M, Castro M. Casos Nuevos de Cáncer en el Instituto Nacional de Cancerología, Colombia, 2002. Rev Colombiana de Cancerol 2003; 7(3):4-19.
4. Limon J. Melanoma, Cytogenetic Studies. Academic Press 2001; pp 1167-1168.
5. Wiltshire R, Dennis T, Sondak V, Meltzer P, Trente J. Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma. Cancer Genet Cytogenet 2001; 131:97-103 (Pubitemid 34003057)
6. Balàzs M, Ádám Z, Bégány Á, Takruri A, Ádány R. Involvement of chromosome losses in the progression and metastasis formation of a human malignant melanoma. Cancer Genet Cytogenet 1999; 109: 114-118. (Pubitemid 29128350)
7. Dracopoli NC, Bale SJ. Genetic aspects of cutaneous malignant melanoma. Semin Oncol 1988; 15:541-548. (Pubitemid 19021096)
8. Cowan JM, Halaban R, Francke U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst 1988; 80:1159-1164. (Pubitemid 18240733)
9. Casorzo L, Luzzi C, Nardacchione A, Picciotto F, Pisacane A, Risio M. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 19 throughout melanocytic tumorigenesis. Melanoma Res 2005; 15: 155-160.
10. Okamoto I, Pirker C, Bilban M, Berger W, Losert D, Marosi C, Haas O, Wolff K, Pehamberger H. Seven novel stable translocation associated with oncogenic gene expression in malignant melanoma. Neoplasia 2005; 7(4): 303-311. (Pubitemid 40664219)
11. Mark N, Radmacher M, Simon R, Aickin M, Yang J, Panda L, Emerson J, Roe D, Adair L, Thompson F, Bangert J, Leong S, Taetle R, Salmon S, Trent J. Chromosome abnormalities in malignant melanoma: clinical significance of non-random chromosome abnormalities in 206 cases. Cancer Genet Cytogenet 2000; 122: 101-109.
12. Brücker E, Magiera H, Herlyn M. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. J Invest Dermatol 1991; 96:662-665.
13. Nagasaki K, Schem C, Von Kaisenberg C, Biallek M, Rosel F, Jonat W, Maass, N. Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer 2003; 105:454-458. (Pubitemid 36578547)
14. Inoue M, Takahashi K, Niide O, Shibata M, Fukuzawa M, Ra C. LDOC1, a novel MZF-1-interacting protein, induces apoptosis. FEBS Lett 2005; 579: 604-608.
15. Westbrook A, Schoppee P, Diekman A, Klotz K, Allietta M Hogan K, Slingluff C, Patterson J, Frierson H, Irvin W, Charles J, Coppola F, Herr J. Genomic organization, incidence and localization of the SPAN-X Family of cancer-testis antigens in melanoma tumors and cell lines. Clin Cancer Res 2004; 10:101-112. (Pubitemid 38114168)
16. Lucas S, De Smet, Karen C, Carrie A, Viars S, Lethà B, Lurquin C, Boon T. Identification of a new MAGE Gene with tumor-specific expression by representational difference analysis. Cancer Res 1998; 58:743-752. (Pubitemid 28099487)
17. Braithwaite A, Royds J, Jackson P. The p53 story: layers of complexity. Carcinogenesis 2005; 26 (7): 1161-1169.
18. Wolfe K, Southern S, Herrington C. Interphase cytogenetic demonstration of chromosome 9 loss in thick melanomas. J Cutan Pathol 1997; 24(7):398-402. (Pubitemid 27374500)
19. Thompson F, Emerson J, Olson S, Weinstein S, Leavitt A, Leong L, Emerson E, Trent J, Nelson M, Salmon S, Taetle R. Cytogenetic of 158 patients with regional or disseminates melanoma. Cancer Genet Cytogenet 1995; 83:93-104.
20. Bastian B, LeBoi P, Hamm H, Bröcker E, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998; 58: 2170-2175. (Pubitemid 28232904)
21. Brossart P. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 1993; 101(6): 887-889. (Pubitemid 23357503)
22. Smith B, Selby P, J Pittman, K Bradley, C Blair. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338(8777): 1227-1229.
23. Ghossein RA, Bhattacharya S, J Rosai. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 1999; 5(8): 1950-1960. (Pubitemid 29399243)